drugset / Trial / NCT00382889
As Needed Beclomethasone/Salbutamol Combination in Single Inhaler for Mild Persistent Asthma
RandomizedParallel-groupDouble-blindTreatment
Summary
The aim of this study is to reveal that inhaled corticosteroid therapy combined with a short-acting beta2- agonist given on a symptom driven basis is as effective as traditional asthma therapy. Thus, three advantages will be achieved: 1. better compliance with treatment since patients will most likely have to administer the treatment less frequently, 2. maximum pharmacological effect with the least amount of drug and 3. less economic burden on health care providers.
Timeline
- Start
- 2002-08
- Primary completion
- —
- Completion
- 2004-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Beclomethasone | Small molecule | 250 ug | Inhaled |
| Subject | Salbutamol | Unknown | 100 ug | Inhaled |